PI3K GENE MUTATION
Clinical trials for PI3K GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new PI3K GENE MUTATION trials appear
Sign up with your email to follow new studies for PI3K GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized pills target root cause of painful vascular growths
Disease control Recruiting nowThis trial is testing two different oral medications for people with abnormal, non-cancerous growths of blood or lymph vessels (vascular malformations). The goal is to see if a year of treatment can reduce patients' most bothersome symptoms and shrink the growths. The specific dr…
Matched conditions: PI3K GENE MUTATION
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
First test of new precision drug targets Cancer's genetic weakness
Disease control Recruiting nowThis is the first study in people for a new drug called OKI-219, designed to target a specific genetic mutation (PI3KαH1047R) found in some advanced cancers. The main goals are to find a safe dose and see how the body handles the drug, both alone and combined with other cancer tr…
Matched conditions: PI3K GENE MUTATION
Phase: PHASE1 • Sponsor: OnKure, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC